𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain

✍ Scribed by Francis X. Walsh; Thomas J. Stevens; Philip J. Langlais; Dr Edward D. Bird


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
442 KB
Volume
12
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Deep brain stimulation of the subthalami
✍ Ruediger Hilker; Juergen Voges; Mehran Ghaemi; Ralf Lehrke; Jobst Rudolf; Athana πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 165 KB

## Abstract Deep brain stimulation of the subthalamic nucleus (STN‐DBS) has become an effective treatment option in advanced Parkinson's disease (PD). Recent animal studies showed an increase of neuronal firing in dopaminergic neurons under effective STN‐DBS. Increased striatal dopamine levels may

Regional localization of dopamine and io
✍ Frank I. Tarazi; Ross J. Baldessarini πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 274 KB

Localization of dopamine (D 1 -, D 2 -like, and D 4 ) and ionotropic glutamate (NMDA, AMPA, and KA) receptor subtypes within the striatolimbic forebrain remains incomplete, but basic to understanding the functional organization of this important brain region. We found that frontal cortical ablation

Serial studies of serum dopamine-B-hydro
✍ Brewster, M. A. ;Berry, D. H. πŸ“‚ Article πŸ“… 1979 πŸ› John Wiley and Sons 🌐 English βš– 407 KB

## Abstract Recent reports have suggested that elevations of serum dopamine‐B‐hydroxylase (DBH) activity may correlate with diagnosis in neuroblastoma patients excreting vanillylmandelic acid (VMA). We have serially studied serum DBH and urinary homovanillic acid (HVA) and VMA excretion during the

Striatal and extrastriatal dopamine in t
✍ Yoland Smith; Rosa Villalba πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 261 KB

Degeneration of the nigrostriatal dopaminergic system is the characteristic neuropathological feature of Parkinson's disease and therapy is primarily based on a dopamine replacement strategy. Dopamine has long been recognized to be a key neuromodulator of basal ganglia function, essential for normal